Stay updated on Ixekizumab for Bullous Pemphigoid Clinical Trial
Sign up to get notified when there's something new on the Ixekizumab for Bullous Pemphigoid Clinical Trial page.

Latest updates to the Ixekizumab for Bullous Pemphigoid Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has undergone significant updates regarding a clinical study on Bullous Pemphigoid (BP), including the introduction of new details about the study's design, treatment approach, and collaborators, while removing extensive background information on BP and Ixekizumab.SummaryDifference51%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Ixekizumab for Bullous Pemphigoid Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixekizumab for Bullous Pemphigoid Clinical Trial page.